Regulatory aspects of fumonisins with respect to animal feed. Animal derived residues in foods.

This paper discusses the regulatory parameters related to fumonisins, a kind of mycotoxin in animal feed, primarily produced by Fusarium fungi. It discusses the adverse impacts of these toxins on animal health, and how they may enter the human food chain, whilst illustrating the regulatory efforts by FDA to monitor and limit these mycotoxins for food safety.

Fumonisins and Their Effects on Animal Health

• The paper begins by introducing fumonisins, a type of mycotoxin primarily produced by the Fusarium species of fungus, which has been discovered to be present in contaminated feed for animals.
• These toxins have been identified as the primary cause of illnesses in animals, such as equine leukoencephalomalacia and porcine pulmonary edema, which are serious neurological and lung conditions in horses and pigs respectively.

FDA’s Regulatory Efforts

• The researchers then discuss the efforts made by the FDA to control these diseases created by feed contamination. Informal guidance levels for fumonisins in feed have been established as a preventive measure.
• Besides just setting acceptable levels, the FDA has also initiated a surveillance program to monitor the presence of fumonisins in feed corn and corn by-products. This was performed during fiscal years 93 and 94.

Fumonisins in the Human Food Chain

• The study also explores the potential for these contaminants present in animal feed to enter the human food supply. This can occur as residues present in animal tissues and other animal derived products.
• The guidance levels for fumonisin contamination were originally set based on animal safety. The FDA also safeguards the human food supply by ensuring that animal products, derived from animals fed mycotoxin-contaminated feed, are safe for human consumption.

Future Regulations and Considerations

• In addition to past and present regulations, the paper also discourses on possible future regulatory requirements given recent pharmacokinetic studies in food-producing animals
• The researchers posit the importance of statutory requirements for regulating natural toxins. This is discussed considering the FDA’s human food safety mandate, which emphasizes the broader implications of fumonisins not just for animal health but also for human safety.